BreathEazy, the leading UK provider of veterinary respiratory technology, including the Flexineb® nebuliser and the AeroHippus® spacer device, is set to return to BEVA after a successful 12 months, which has seen the company go from strength to strength. The company’s growth is in part down to a growing recognition of the benefits of nebulised medication for the management of equine respiratory disease but also its benefits for routine airway maintenance therapy, helping to minimise the impact of respiratory issues on performance.
Nebulisation enables delivery of medications direct to the lungs and lower airways, reducing the side effects that may be associated with systemic administration. For example, corticosteroids are one of the most effective drug therapies for managing equine asthma due to their potent anti-inflammatory action(1,2), but while effective, they can cause significant side effects, including adrenal suppression and immunosuppression.(3)
Jon Slattery MRCVS, Director of BreathEazy, explains, “By directly targeting the site of disease pathology, inhaled therapy achieves the same therapeutic effect as systemic medication but with substantially lower doses and improved outcomes for patients.”
Nebulisers can also be used for non-drug therapies, such as vaporising saline to reduce mucus and airway congestion. This can be particularly beneficial for competition horses including racehorses and eventers, where maintaining respiratory health is crucial for optimal performance but FEI regulations and drug withdrawal times need to be considered. Inhaled non-drug therapies can also be helpful in the ongoing management of respiratory disease in pleasure or non-competition horses once their initial clinical signs have been controlled.
BreathEazy’s commitment to advancing equine respiratory care has been instrumental in its success over the past year. At BEVA, the company will be showcasing its range of equine respiratory technology, including the AeroHippus® spacer device and the Flexineb® equine nebuliser. Delegates are encouraged to visit stand D6 to find out how the company’s innovative solutions can enhance the management of a number of respiratory conditions including equine asthma.
To find out more about how inhaled therapies can benefit your patients, come and see us on stand D6 or visit breatheazy.co.uk.
Press contact: Katy Ellison, katy@companionconsultancy.com, Tel 07596 217372
About Flexineb® E3 nebuliser
The Flexineb® E3 delivers aerosolised medication and natural therapies to the airways of horses.
• Rapid, effective nebulisation
• Vibrating mesh technology for faster treatment times
• Targeted delivery to the lungs and small airways
• Lightweight and portable
• Silent in use
• Battery or mains operated
• Up to 6 hours use from a single charge
• Available in foal, standard and large sizes
About AeroHippus®
The AeroHippus® Chamber is a spacer device tailored to the needs of equine asthma patients.
• Vet tested, equine approved aerosol holding chamber (spacer) for horses with asthma, Respiratory Airway Obstruction (RAO/heaves), COPD, and breathing difficulties
• Confidence in medication delivery with the Flow-Vu* inhalation indicator which helps track breaths taken and ensure mask seal
• Holds medication longer so more time to deliver the medications
• Makes more medication available from each puff: better performance means less waste and savings on drug cost
• Easy to use: the antistatic equine aerosol chamber helps deliver any Metered Dose Inhaler medication to the lungs
• Designed for horses with custom valves, and a mask that fits all horses and ponies
References
1. Couetil, L.L. et al. (2016) Inflammatory airway disease of horses-revised consensus statement. J. Vet. Intern. Med. 30, 503-515
2. Leclere, M., Lavoie-Lamoureux, A. & Lavoie, J.P. (2011) Heaves, an asthma-like disease of horses. Respirology 16, 1027-1046.
3. Pirie, R.S. & McGorum, B. (2017) Inhalation therapy for equine lower respiratory disease. In Practice, vol. 39, no. 7, pp. 317-327. https://doi.org/10.1136/inp.j2879
About BreathEazy
BreathEazy provides a range of technological veterinary solutions to support the management of respiratory diseases in horses, dogs, cats, birds and exotics. Founded and run by a veterinary surgeon, the goal of improving respiratory health for animals, is at the heart of everything the company does.
As the official UK distributor of the AeroKat®, AeroDawg®, AeroHippus® and Flexineb® range of products, BreathEazy supplies direct to both veterinary clinics and pet owners.
From feline asthma to canine chronic bronchitis and equine respiratory disease, look no further than BreathEazy’s solutions to help support respiratory health in companion animals.
Comments